Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
09/2001
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/19/2001EP0869952B1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof
09/19/2001CN1313858A Manufacture of 1,3-oxathiolane nucleosides
09/18/2001US6291701 Used as chemical intermeidate
09/18/2001US6291400 Herbicidal compounds
09/13/2001US20010021709 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy
09/12/2001EP1132386A1 Amido compounds and process for producing the same
09/12/2001EP1132377A1 Propiolonitrile derivatives and liquid crystal compositions comprising the same
09/12/2001EP1132373A2 New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
09/12/2001CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
09/12/2001CN1070841C Carboxylic acid derivatives, their preparation and their use
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them
09/07/2001WO2001064814A1 Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds
09/07/2001WO2001064666A1 Oxygen-containing heterocyclic compounds
09/07/2001CA2401489A1 Oxygen-containing heterocyclic compounds
09/06/2001US20010020103 Reacting a 6-halomethyl-4H-1,3-dioxin-4-one derivative with carbon monoxide and an alcohol or water
09/05/2001CN1311679A Benzimidazole derivatives as modulators of IgE
09/05/2001CN1311675A Compounds having IgE affecting properties
09/04/2001USRE37355 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/04/2001CA2173408C Process for the manufacture of intermediates suitable to make doxazosin,terazosin, prazosin, tiodazosin and related antihypertensive medicines
08/2001
08/30/2001US20010018529 Chemical intermediate for antidiabetic drug
08/30/2001DE10102631A1 Thiophencarbonsäureester und flüssigkristallines Medium Thiophencarbonsäureester and liquid crystalline medium
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/29/2001CN1310161A Formaldehyde acrolactic ester etherified glycerine acetal and its synthesis process
08/28/2001US6281214 Biphenyl derivatives
08/23/2001WO2001060812A1 Dioxin derivatives and method of measurement therewith
08/23/2001WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives
08/23/2001US20010016664 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application
08/23/2001CA2400840A1 Dioxin derivatives and method of measurement therewith
08/22/2001EP1125908A1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application
08/22/2001CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
08/21/2001US6277867 Synergistic mixtures
08/16/2001WO2000047551A3 Inhibitors of aspartyl protease
08/16/2001US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
08/16/2001US20010014646 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
08/15/2001CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
08/14/2001US6274600 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors
08/09/2001WO2001056538A1 Novel coupler for use in oxidative hair dyeing
08/07/2001US6271398 Process for producing simvastatin and/or its derivatives
08/07/2001US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs
08/01/2001CN1305994A Tert-butyl (3R, 5R)-3,5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and application
08/01/2001CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor
07/2001
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/31/2001US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/25/2001EP1117636A1 Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1304921A Method of using easy removed nitroxyl selective alcohol axide
07/24/2001CA2177774C Novel piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds; process_for preparing the same and pharmaceutical compositions containing them
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001CN1304408A N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/17/2001US6261738 Latent curing catalysts for photoresists such as 2,2,2-trifluoro-1-phenyl-ethanone oxime-o-methyl sulfonate
07/12/2001WO2001049683A1 Novel heteroaryl derivatives, their preparation and use
07/12/2001WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives
07/12/2001WO2001049288A1 Novel compounds and compositions as protease inhibitors
07/12/2001WO2001002391A3 Bicyclic aromatic compounds for treating drug addiction
07/12/2001DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives
07/12/2001CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives
07/12/2001CA2396257A1 Novel compounds and compositions as protease inhibitors
07/12/2001CA2395984A1 Novel heteroaryl derivatives, their preparation and use
07/11/2001EP1114668A1 Process and apparatus for treating dioxins
07/11/2001EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines
07/11/2001EP0920405B1 Fluorovinyl derivative compound, liquid crystal composition, and liquid crystal display device
07/10/2001US6258962 Reacting alkylene oxide with carbon dioxide
07/10/2001US6258603 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
07/05/2001WO2001021613A8 Process for the preparation of cyclic lactic acid oligomers
07/05/2001DE19962346A1 Preparation of 5-disubstituted 1,3-dioxan-4,6-diones un-, mono- or di-substituted in the 2-position comprises reacting the components whilst simultaneously crystallizing and/or distilling
07/03/2001US6255528 Reacting an alkylfluorobromobenzene or fluorobromobenzene with acrylamide in presence of palladium catalyst, hydrogenating the resulting arylacrylamide, and then rearranging it
06/2001
06/28/2001WO2001045694A1 Urotensin-ii receptor antagonists
06/28/2001US20010005753 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
06/28/2001CA2394603A1 Urotensin-ii receptor antagonists
06/27/2001EP1110961A1 Oxygenic heterocyclic compounds
06/27/2001EP0847432B1 Polymerizable liquid-crystalline compounds
06/21/2001US20010004668 By reaction of 2-amino-6-chloropurine with 2-acetoxymethyl-4-(leaving group)-but-1-yl acetate to give 9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-amino- 6-chloropurine, thereafter hydrolysing or reducing
06/20/2001EP0890176B1 Proton conductor in liquid form
06/20/2001CN1300288A Water soluble azoles as broad-spectrum antifungals
06/20/2001CN1300287A Water soluble azoles as broad-spectrum antifungals
06/20/2001CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
06/20/2001CN1299819A (R)-2[3-(2-N-phthalic amido ethyl)-4,5-dihydro-5-isoxazolyl]-acetic acid and its synthesis
06/19/2001US6248907 Alpha 1 and alpha 2 adrenoceptor antagonistic effects and urogenital selectivity; benign prostate hyperplasia; dibenzoyltartrate salt
06/19/2001US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects
06/14/2001WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide
06/14/2001CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2001EP1105383A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/13/2001DE19959000A1 New primary monoalkyl ethers of autocondensation products of glycerol and mixtures are used in production of nutrient and surfactant formulations, such as cosmetics, pharmaceuticals, laundry or other detergents
06/13/2001CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof
06/12/2001US6245871 Group 8-10 transition metal olefin polymerization catalysts
06/12/2001US6245449 Material for organoelectroluminescence device and use thereof
06/07/2001WO2001040214A1 Bryostatin analogues, synthetic methods and uses
06/07/2001CA2393026A1 Bryostatin analogues, synthetic methods and uses
06/06/2001EP1104750A1 Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
06/06/2001EP1104415A1 Method of manufacture of 1,3-oxathiolane nucleosides
06/06/2001CN1298400A Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 103